NEULAND LABORATORIES
|
NEULAND LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity - Authorised | ₹44 Cr | ₹44 Cr | ₹44 Cr | ₹44 Cr | ₹44 Cr |
Equity - Issued | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity Paid Up | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity Shares Forfeited | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr | ₹0.07 Cr |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹1,512 Cr | ₹1,270 Cr | ₹981 Cr | ₹828 Cr | ₹774 Cr |
Securities Premium | ₹498 Cr | ₹498 Cr | ₹498 Cr | ₹498 Cr | ₹498 Cr |
Capital Reserves | ₹0.03 Cr | ₹0.03 Cr | ₹0.03 Cr | ₹0.03 Cr | ₹0.03 Cr |
Profit & Loss Account Balance | ₹995 Cr | ₹752 Cr | ₹465 Cr | ₹308 Cr | ₹248 Cr |
General Reserves | ₹28 Cr | ₹28 Cr | ₹28 Cr | ₹28 Cr | ₹28 Cr |
Other Reserves | ₹-8.43 Cr | ₹-8.38 Cr | ₹-9.74 Cr | ₹-6.24 Cr | ₹-0.31 Cr |
Reserve excluding Revaluation Reserve | ₹1,511 Cr | ₹1,269 Cr | ₹980 Cr | ₹827 Cr | ₹773 Cr |
Revaluation reserve | ₹0.84 Cr | ₹0.84 Cr | ₹0.84 Cr | ₹0.84 Cr | ₹0.84 Cr |
Shareholder's Funds | ₹1,525 Cr | ₹1,283 Cr | ₹994 Cr | ₹841 Cr | ₹786 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹91 Cr | ₹45 Cr | ₹74 Cr | ₹104 Cr | ₹88 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹131 Cr | ₹72 Cr | ₹106 Cr | ₹135 Cr | ₹110 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-40 Cr | ₹-27 Cr | ₹-32 Cr | ₹-30 Cr | ₹-22 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹73 Cr | ₹60 Cr | ₹58 Cr | ₹57 Cr | ₹60 Cr |
Deferred Tax Assets | ₹3.34 Cr | ₹13 Cr | ₹14 Cr | ₹17 Cr | ₹10 Cr |
Deferred Tax Liability | ₹76 Cr | ₹73 Cr | ₹72 Cr | ₹73 Cr | ₹70 Cr |
Other Long Term Liabilities | ₹19 Cr | ₹9.20 Cr | ₹3.88 Cr | ₹6.97 Cr | ₹12 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹7.22 Cr | ₹7.61 Cr | ₹10 Cr | ₹12 Cr | ₹9.44 Cr |
Total Non-Current Liabilities | ₹189 Cr | ₹122 Cr | ₹147 Cr | ₹180 Cr | ₹170 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹252 Cr | ₹192 Cr | ₹171 Cr | ₹117 Cr | ₹152 Cr |
Sundry Creditors | ₹252 Cr | ₹192 Cr | ₹171 Cr | ₹117 Cr | ₹152 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹211 Cr | ₹234 Cr | ₹245 Cr | ₹152 Cr | ₹159 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹73 Cr | ₹81 Cr | ₹137 Cr | ₹63 Cr | ₹64 Cr |
Interest Accrued But Not Due | ₹0.24 Cr | ₹0.64 Cr | ₹0.25 Cr | ₹0.33 Cr | ₹0.40 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹138 Cr | ₹152 Cr | ₹108 Cr | ₹89 Cr | ₹95 Cr |
Short Term Borrowings | - | - | ₹11 Cr | ₹92 Cr | ₹57 Cr |
Secured ST Loans repayable on Demands | - | - | ₹11 Cr | ₹92 Cr | ₹57 Cr |
Working Capital Loans- Sec | - | - | ₹11 Cr | ₹92 Cr | ₹57 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | ₹-11 Cr | ₹-92 Cr | ₹-57 Cr |
Short Term Provisions | ₹2.19 Cr | ₹1.72 Cr | ₹12 Cr | ₹1.21 Cr | ₹0.64 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹0.09 Cr | ₹0.08 Cr | ₹10 Cr | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹2.10 Cr | ₹1.64 Cr | ₹1.53 Cr | ₹1.21 Cr | ₹0.64 Cr |
Total Current Liabilities | ₹466 Cr | ₹428 Cr | ₹439 Cr | ₹363 Cr | ₹369 Cr |
Total Liabilities | ₹2,180 Cr | ₹1,833 Cr | ₹1,580 Cr | ₹1,383 Cr | ₹1,325 Cr |
ASSETS | |||||
Gross Block | ₹1,238 Cr | ₹1,070 Cr | ₹950 Cr | ₹913 Cr | ₹826 Cr |
Less: Accumulated Depreciation | ₹283 Cr | ₹265 Cr | ₹212 Cr | ₹166 Cr | ₹130 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹955 Cr | ₹805 Cr | ₹738 Cr | ₹748 Cr | ₹697 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹45 Cr | ₹46 Cr | ₹41 Cr | ₹20 Cr | ₹17 Cr |
Non Current Investments | ₹1.53 Cr | ₹1.28 Cr | ₹0.53 Cr | ₹0.50 Cr | ₹0.44 Cr |
Long Term Investment | ₹1.53 Cr | ₹1.28 Cr | ₹0.53 Cr | ₹0.50 Cr | ₹0.44 Cr |
Quoted | - | - | ₹0.28 Cr | ₹0.25 Cr | ₹0.19 Cr |
Unquoted | ₹1.53 Cr | ₹1.28 Cr | ₹0.25 Cr | ₹0.25 Cr | ₹0.25 Cr |
Long Term Loans & Advances | ₹36 Cr | ₹40 Cr | ₹20 Cr | ₹14 Cr | ₹42 Cr |
Other Non Current Assets | ₹0.24 Cr | ₹0.17 Cr | - | - | - |
Total Non-Current Assets | ₹1,040 Cr | ₹911 Cr | ₹819 Cr | ₹803 Cr | ₹775 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹108 Cr | - | - | ₹3.38 Cr | ₹6.46 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹108 Cr | - | - | ₹3.38 Cr | ₹6.46 Cr |
Inventories | ₹386 Cr | ₹350 Cr | ₹279 Cr | ₹265 Cr | ₹248 Cr |
Raw Materials | ₹142 Cr | ₹99 Cr | ₹81 Cr | ₹78 Cr | ₹79 Cr |
Work-in Progress | ₹155 Cr | ₹148 Cr | ₹118 Cr | ₹119 Cr | ₹108 Cr |
Finished Goods | ₹69 Cr | ₹89 Cr | ₹64 Cr | ₹53 Cr | ₹49 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | ₹20 Cr | ₹15 Cr | ₹17 Cr | ₹15 Cr | ₹12 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹316 Cr | ₹374 Cr | ₹362 Cr | ₹234 Cr | ₹218 Cr |
Debtors more than Six months | ₹2.19 Cr | ₹2.88 Cr | ₹3.70 Cr | ₹4.13 Cr | ₹7.55 Cr |
Debtors Others | ₹316 Cr | ₹371 Cr | ₹362 Cr | ₹234 Cr | ₹214 Cr |
Cash and Bank | ₹259 Cr | ₹117 Cr | ₹59 Cr | ₹20 Cr | ₹19 Cr |
Cash in hand | ₹0.04 Cr | ₹0.04 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.03 Cr |
Balances at Bank | ₹259 Cr | ₹117 Cr | ₹59 Cr | ₹20 Cr | ₹19 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹20 Cr | ₹18 Cr | ₹14 Cr | ₹12 Cr | ₹8.84 Cr |
Interest accrued on Investments | ₹1.72 Cr | ₹0.42 Cr | ₹0.09 Cr | ₹0.07 Cr | ₹0.17 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹12 Cr | ₹11 Cr | ₹11 Cr | ₹7.42 Cr | ₹7.18 Cr |
Other current_assets | ₹6.26 Cr | ₹6.74 Cr | ₹3.07 Cr | ₹4.03 Cr | ₹1.50 Cr |
Short Term Loans and Advances | ₹52 Cr | ₹62 Cr | ₹47 Cr | ₹46 Cr | ₹50 Cr |
Advances recoverable in cash or in kind | ₹23 Cr | ₹19 Cr | ₹25 Cr | ₹21 Cr | ₹23 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹29 Cr | ₹43 Cr | ₹22 Cr | ₹25 Cr | ₹27 Cr |
Total Current Assets | ₹1,139 Cr | ₹921 Cr | ₹761 Cr | ₹581 Cr | ₹550 Cr |
Net Current Assets (Including Current Investments) | ₹674 Cr | ₹493 Cr | ₹322 Cr | ₹218 Cr | ₹181 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹2,180 Cr | ₹1,833 Cr | ₹1,580 Cr | ₹1,383 Cr | ₹1,325 Cr |
Contingent Liabilities | ₹8.97 Cr | ₹28 Cr | ₹91 Cr | ₹75 Cr | ₹105 Cr |
Total Debt | ₹136 Cr | ₹83 Cr | ₹122 Cr | ₹231 Cr | ₹170 Cr |
Book Value | 1,187.77 | 999.07 | 774.12 | 654.40 | 612.28 |
Adjusted Book Value | 1,187.77 | 999.07 | 774.12 | 654.40 | 612.28 |
Compare Balance Sheet of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹15,323.1 Cr | 2.8% | -5.5% | 50.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,005.0 Cr | -0.7% | -1.3% | 6.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹185,609.0 Cr | 1.8% | 4.8% | 49.8% | Stock Analytics | |
CIPLA | ₹120,500.0 Cr | -1.1% | -1.3% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,530.0 Cr | 0.6% | 4.2% | 15.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,954.0 Cr | -1.8% | -6% | -1.6% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 2.8% |
-5.5% |
50.3% |
SENSEX | 0.2% |
1.3% |
4.4% |
You may also like the below Video Courses